Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888989 · ClinicalTrials.gov registry record · Phase 1
Response to Influenza Vaccine During Pregnancy
A Phase 1 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT03888989: Clinical Trial Phase 1 study, sponsored by Stanford University.
NCT03888989 is a Phase 1 study that was terminated before completion, run by Stanford University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03888989, a Phase 1 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to investigate the immune response to vaccination in pregnancy.
Interventions
- BIOLOGICAL Quadrivalent inactivated influenza vaccine (IIV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2023-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03888989
The ClinicalTrials.gov registry entry for NCT03888989 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quadrivalent inactivated influenza vaccine (IIV) is the first listed.
NCT03888989 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03888989 about?
NCT03888989 is a clinical study titled "Response to Influenza Vaccine During Pregnancy". This is one project of a larger ongoing study related to the immune system's response to the flu virus. This study is designed to investigate the immune response to vaccination in pregnancy.
What is the current status of trial NCT03888989?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2019-09-30. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT03888989?
The interventions under investigation include: Quadrivalent inactivated influenza vaccine (IIV) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03888989?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.